Drug maker Eli Lilly swung to a fourth-quarter net loss as it booked a $4.73 billion charge for its November acquisition of ImClone.
WSJ.com: What's News US, Wall Street Journal
Thu, 01/29/2009 - 5:33am
Drug maker Eli Lilly swung to a fourth-quarter net loss as it booked a $4.73 billion charge for its November acquisition of ImClone.